» Articles » PMID: 33485299

Anemia As a Risk Factor for Tuberculosis: a Systematic Review and Meta-analysis

Overview
Date 2021 Jan 24
PMID 33485299
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tuberculosis is a major public health problem caused by Mycobacterium tuberculosis, occurring predominantly in population with low socioeconomic status. It is the second most common cause of death from infectious diseases. Tuberculosis becomes a double burden among anemic patients. Anemia increases an individual's susceptibility to infectious diseases including tuberculosis by reducing the immunity level. Therefore, the purpose of this study was to determine whether anemia is a risk factor for tuberculosis.

Method: Relevant published articles were searched in electronic databases like PubMed, Google Scholar, EMBASE, and Cochrane Library using the following MeSH terms: risk factor, predictors, tuberculosis, TB, Anaemia, Anemia, hemoglobin, Hgb, and Hb. Articles written in the English, observational studies conducted on the incidence/prevalence of tuberculosis among anemic patients, or papers examined anemia as risk factors for tuberculosis were included. From those studies meeting eligibility criteria, the first author's name, publication year, study area, sample size and age of participants, study design, and effect measure of anemia for tuberculosis were extracted. The data were entered using Microsoft Excel and exported to Stata version 11 for analysis. The random-effects model was applied to estimate the pooled OR and HR, and 95% CI. The sources of heterogeneity were tested by Cochrane I-squared statistics. The publication bias was assessed using Egger's test statistics.

Results: A total of 17 articles with a 215,294 study participants were included in the analysis. The odd of tuberculosis among anemic patients was 3.56 (95% CI 2.53-5.01) times higher than non-anemic patients. The cohort studies showed that the HR of tuberculosis was 2.01 (95% CI 1.70-2.37) times higher among anemic patients than non-anemic patients. The hazard of tuberculosis also increased with anemia severity (HR 1.37 (95% CI 0.92-2.05), 2.08 (95% CI 1.14-3.79), and 2.66 (95% CI 1.71-4.13) for mild, moderate, and severe anemia, respectively).

Conclusion: According to the current systematic review and meta-analysis, we can conclude that anemia was a risk factor for tuberculosis. Therefore, anemia screening, early diagnose, and treatment should be provoked in the community to reduce the burden of tuberculosis.

Citing Articles

Association between occupational exposure to gasoline and anemia: a retrospective cohort study in China.

Lin L, Cao H, Wu B, Wang J, Song L, Chan W BMC Public Health. 2025; 25(1):330.

PMID: 39871221 PMC: 11771115. DOI: 10.1186/s12889-025-21575-0.


unseen: 2. Anaemia affects urban rich Nigerian adolescents more than other socio‑economic status groups.

Ejike C, Igwe-Ogbonna N, Uwadoka N Ann Glob Health. 2024; 90(1):65.

PMID: 39525391 PMC: 11545919. DOI: 10.5334/aogh.4551.


Burden of mortality and its predictors among TB-HIV co-infected patients in Ethiopia: Systematic review and meta-analysis.

Kassaw A, Kefale D, Aytenew T, Azmeraw M, Agimas M, Zeleke S PLoS One. 2024; 19(11):e0312698.

PMID: 39509354 PMC: 11542784. DOI: 10.1371/journal.pone.0312698.


Role of ethnicity and residency in active tuberculosis in Karakalpakstan: study protocol of a matched case-control study.

Asadov D, Aripov T, Alaverdyan S, Sadikkhodjayeva D, Yuldashev G, Allakova N BMJ Open Respir Res. 2024; 11(1).

PMID: 39461844 PMC: 11529768. DOI: 10.1136/bmjresp-2024-002554.


Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches.

Bartolomeu-Goncalves G, Souza J, Fernandes B, Spoladori L, Correia G, Castro I Diseases. 2024; 12(9).

PMID: 39329871 PMC: 11430992. DOI: 10.3390/diseases12090202.


References
1.
McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B . Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008; 12(4):444-54. DOI: 10.1017/S1368980008002401. View

2.
Chang C, Meloni S, Eisen G, Chaplin B, Akande P, Okonkwo P . Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infect Dis. 2015; 2(4):ofv154. PMC: 4654399. DOI: 10.1093/ofid/ofv154. View

3.
Erkurt M, Aydogdu I, Dikilitas M, Kuku I, Kaya E, Bayraktar N . Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008; 17(2):131-5. DOI: 10.1159/000112967. View

4.
Kerkhoff A, Wood R, Cobelens F, Gupta-Wright A, Bekker L, Lawn S . The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med. 2015; 13:70. PMC: 4411796. DOI: 10.1186/s12916-015-0320-9. View

5.
Buttari B, Profumo E, Rigano R . Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. Biomed Res Int. 2015; 2015:616834. PMC: 4334626. DOI: 10.1155/2015/616834. View